X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA STRIDES SHASUN LTD SHASUN PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x 123.9 14.1 879.6% View Chart
P/BV x 8.5 1.9 447.8% View Chart
Dividend Yield % 0.2 0.5 42.7%  

Financials

 SHASUN PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
STRIDES SHASUN LTD
Mar-16
SHASUN PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs941,413 6.7%   
Low Rs46848 5.4%   
Sales per share (Unadj.) Rs214.2353.3 60.6%  
Earnings per share (Unadj.) Rs5.323.4 22.8%  
Cash flow per share (Unadj.) Rs15.841.0 38.6%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %1.40.4 323.4%  
Book value per share (Unadj.) Rs53.3320.4 16.6%  
Shares outstanding (eoy) m56.6289.35 63.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.33.2 10.2%   
Avg P/E ratio x13.148.3 27.1%  
P/CF ratio (eoy) x4.427.6 16.0%  
Price / Book Value ratio x1.33.5 37.2%  
Dividend payout %18.721.4 87.6%   
Avg Mkt Cap Rs m3,958100,988 3.9%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m2,1644,988 43.4%   
Avg. sales/employee Rs ThNM6,730.0-  
Avg. wages/employee Rs ThNM1,063.6-  
Avg. net profit/employee Rs ThNM445.5-  
INCOME DATA
Net Sales Rs m12,12731,564 38.4%  
Other income Rs m2291,212 18.9%   
Total revenues Rs m12,35632,776 37.7%   
Gross profit Rs m1,0095,213 19.4%  
Depreciation Rs m5941,573 37.7%   
Interest Rs m4151,803 23.0%   
Profit before tax Rs m2303,049 7.5%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m0-27 1.1%   
Extraordinary Inc (Exp) Rs m0-371 0.0%   
Tax Rs m-73689 -10.6%   
Profit after tax Rs m3022,089 14.5%  
Gross profit margin %8.316.5 50.4%  
Effective tax rate %-31.722.6 -140.2%   
Net profit margin %2.56.6 37.6%  
BALANCE SHEET DATA
Current assets Rs m6,88435,949 19.2%   
Current liabilities Rs m8,45619,402 43.6%   
Net working cap to sales %-13.052.4 -24.7%  
Current ratio x0.81.9 43.9%  
Inventory Days Days6271 86.9%  
Debtors Days Days108127 84.8%  
Net fixed assets Rs m4,97034,478 14.4%   
Share capital Rs m113894 12.7%   
"Free" reserves Rs m2,87522,601 12.7%   
Net worth Rs m3,02028,632 10.5%   
Long term debt Rs m1,81727,455 6.6%   
Total assets Rs m13,34776,591 17.4%  
Interest coverage x1.62.7 57.7%   
Debt to equity ratio x0.61.0 62.8%  
Sales to assets ratio x0.90.4 220.5%   
Return on assets %5.45.1 105.7%  
Return on equity %10.07.3 137.1%  
Return on capital %13.38.2 163.1%  
Exports to sales %46.448.1 96.3%   
Imports to sales %14.214.5 98.5%   
Exports (fob) Rs m5,62215,192 37.0%   
Imports (cif) Rs m1,7284,565 37.8%   
Fx inflow Rs m5,84316,612 35.2%   
Fx outflow Rs m2,1735,292 41.1%   
Net fx Rs m3,66911,320 32.4%   
CASH FLOW
From Operations Rs m398717 55.5%  
From Investments Rs m-1,635-22,284 7.3%  
From Financial Activity Rs m1,30929,488 4.4%  
Net Cashflow Rs m718,073 0.9%  

Share Holding

Indian Promoters % 39.2 27.7 141.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 37.8 9.5%  
FIIs % 17.6 8.6 204.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.9 152.9%  
Shareholders   20,750 56,241 36.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare SHASUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS